MOYES JAY M 4

What Happened

• Jay M. Moyes, a director of BioCardia, Inc. (BCDA), was granted a derivative equity award for 8,000 shares on July 6, 2026. The reported acquisition price is $0.00 (no cash paid at grant); the grant is coded as an award/derivative (Form 4 code A).

Key Details

• Transaction date: 2026-07-06; Form 4 filed: 2026-07-07 (timely filing).
• Grant: 8,000 derivative shares; reported price $0.00; reported acquisition value $0.
• Vesting/exercise note: Footnote F1 — 100% of the shares vest and become exercisable on the one‑year anniversary of the grant, contingent on the reporting person continuing as a service provider through that date.
• Shares owned after transaction: not specified in the provided filing.
• Filing timeliness: Filed next day (no late-report indication).

Context

• This is a time‑based equity award to a director that does not immediately transfer tradable shares to the market; the award vests and becomes exercisable only after one year of continued service. Such grants are commonly part of director compensation and are not the same as an open‑market purchase or sale.